Skip to main content
Premium Trial:

Request an Annual Quote

Macrogen Named Roche NimbleGen CSP

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche NimbleGen today said that it has named Macrogen a Certified Service Provider for Korea.

Specifically, Macrogen has joined the CSP program for offering services using NimbleGen's Comparative Genomic Hybridization/Copy Number Variation services in its lab in Seoul, South Korea. Macrogen will process gDNA samples for CGH/CNV using the complete NimbleGen array CGH workflow including the high-resolution MS 200 Microarray Scanner.

Macrogen had used the NimbleGen aCGH microarrays as part of its efforts for the Korea Centers for Disease Control and Prevention's CNV projects. That project was a two-phase study, which included a large-scale characterization of CNVs in Korean populations and analysis of common CNVs in genome-wide association studies for 6,000 Korean individuals, said Roche in a statement.

The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.